Evidence map›Paper›PMID 34443742›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Synthesis and Characterization of Photoluminescent Ce(III) and Ce(IV) Substituted Hydroxyapatite Nanomaterials by Co-Precipitation Method: Cytotoxicity and Biocompatibility Evaluation.

Andrei Viorel Paduraru, Adina Magdalena Musuc, Ovidiu Cristian Oprea, Roxana Trusca, Florin Iordache, Bogdan Stefan Vasile, Ecaterina Andronescu

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Lanthanides-Substituted Hydroxyapatite for Biomedical Applications.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrei Viorel PaduraruFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.
Adina Magdalena MusucFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.ORCID 0000-0002-6935-8065
Ovidiu Cristian OpreaFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.ORCID 0000-0002-8145-1094
Roxana TruscaFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.
Florin IordacheFaculty of Veterinary Medicine, Department of Biochemistry, University of Agronomic Science and Veterinary Medicine, 011464 Bucharest, Romania.ORCID 0000-0002-5366-6792
Bogdan Stefan VasileFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.ORCID 0000-0002-2267-6453
Ecaterina AndronescuFaculty of Applied Chemistry and Materials Science, Department of Science and Engineering of Oxide Materials and Nanomaterials, University "Politehnica" of Bucharest, 060042 Bucharest, Romania.ORCID 0000-0002-2226-5849

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improved compounds of Ce(III) and Ce(IV)-doped hydroxyapatite (Ca

Indexed as

biocompatibility evaluationcerium ionshydroxyapatitephotoluminescence

Identifiers

PMID34443742
PMCPMC8399908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.